122 related articles for article (PubMed ID: 36250543)
41. Development and validation of prognostic nomogram for lung cancer patients below the age of 45 years.
Dai L; Wang W; Liu Q; Xia T; Wang Q; Chen Q; Zhu N; Cheng Y; Yan Y; Shu J; Qu K
Bosn J Basic Med Sci; 2021 Jun; 21(3):352-363. PubMed ID: 33091332
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
43. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
44. A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters.
Wang W; Li X; Gao Y; Zheng H; Gao M
BMC Cancer; 2023 Aug; 23(1):720. PubMed ID: 37528420
[TBL] [Abstract][Full Text] [Related]
45. MRI-based radiomics nomogram for the preoperative prediction of deep myometrial invasion of FIGO stage I endometrial carcinoma.
Zhao M; Wen F; Shi J; Song J; Zhao J; Song Q; Lai Q; Luo Y; Yu T; Jiang X; Jiang W; Dong Y
Med Phys; 2022 Oct; 49(10):6505-6516. PubMed ID: 35758644
[TBL] [Abstract][Full Text] [Related]
46. A risk prediction nomogram of endometrial carcinoma and precancerous lesions in postmenopausal women: A retrospective study.
Wang J; Gao S; Wang J; Wang T
Medicine (Baltimore); 2023 Feb; 102(8):e33087. PubMed ID: 36827011
[TBL] [Abstract][Full Text] [Related]
47. Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer.
Chen H; Wu Q; Zhang Y; Li Q; Ma J; Kong F; Ma X
Gynecol Oncol; 2020 Sep; 158(3):689-697. PubMed ID: 32507649
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.
Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G
Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408
[TBL] [Abstract][Full Text] [Related]
49. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.
He T; Chen T; Liu X; Zhang B; Yue S; Cao J; Zhang G
Front Public Health; 2021; 9():789026. PubMed ID: 35096742
[No Abstract] [Full Text] [Related]
50. [Establishment and effect evaluation of nomogram model for diagnosis and prediction of pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Zhou DS; Xu L; Zhang Y; Zhang TT; Chen YQ; Chen JY; Zhang J; Liu CL; Wang J
Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(38):3019-3025. PubMed ID: 36229203
[No Abstract] [Full Text] [Related]
51. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
[TBL] [Abstract][Full Text] [Related]
52. Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.
Yin R; Wang G; Yang X; Zhang L; Wang S; Li T; Liu S
Clin Rheumatol; 2021 Oct; 40(10):3951-3960. PubMed ID: 34002352
[TBL] [Abstract][Full Text] [Related]
53. The risk factors and predictive nomogram of human albumin infusion during the perioperative period of posterior lumbar interbody fusion: a study based on 2015-2020 data from a local hospital.
Liu B; Pan J; Zong H; Wang Z
J Orthop Surg Res; 2021 Oct; 16(1):654. PubMed ID: 34717707
[TBL] [Abstract][Full Text] [Related]
54. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H
J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695
[TBL] [Abstract][Full Text] [Related]
55. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
56. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study.
Deng S; Jiang Z; Cao Y; Gu J; Mao F; Xue Y; Qin L; Liu K; Wang J; Wu K; Cai K
BMC Cancer; 2022 Jun; 22(1):643. PubMed ID: 35690752
[TBL] [Abstract][Full Text] [Related]
58. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
59. Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction.
Wang C; Xu Y; Lin Y; Zhou Y; Mao F; Zhang X; Shen S; Zhang Y; Sun Q
Breast; 2022 Jun; 63():61-70. PubMed ID: 35334240
[TBL] [Abstract][Full Text] [Related]
60. A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer.
Lee SB; Kim J; Sohn G; Kim J; Chung IY; Kim HJ; Ko BS; Son BH; Ahn SH; Lee JW; Jung KH
Cancer Res Treat; 2019 Jul; 51(3):1073-1085. PubMed ID: 30384581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
